Clinical Trials Browser

Phase 1/2 × Uveal Melanoma × aldesleukin × Clear all

NCT07063875 2025-07-14

SILVER

Phase 1/2 Recruiting

Uveal Melanoma

NCT00058279 2013-06-20

Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

Phase 1/2 Completed

Uveal Melanoma, Melanoma